Search Results - "Evoli, Amelia"

Paraneoplastic disorders in thymoma patients by Evoli, Amelia, Lancaster, Eric

“…Thymic malignancy is often associated with paraneoplastic neurological diseases (PNDs) and recognition of these disorders is important for physicians who treat…”
Get more information

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders by Punga, Anna Rostedt, Maddison, Paul, Heckmann, Jeannine M, Guptill, Jeffrey T, Evoli, Amelia

“…Autoimmune neuromuscular junction disorders are rare. However, myasthenia gravis is being increasingly recognised in people older than 50 years. In the past…”
Get full text

Myasthenia gravis by Gilhus, Nils Erik, Tzartos, Socrates, Evoli, Amelia, Palace, Jacqueline, Burns, Ted M., Verschuuren, Jan J. G. M.

“…Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or other…”
Get full text

Controversies in Ocular Myasthenia Gravis by Evoli, Amelia, Iorio, Raffaele

“…Myasthenia gravis (MG) with symptoms limited to eye muscles [ocular MG (OMG)] is a rare disease. OMG incidence varies according to ethnicity and age of onset…”
Get full text

Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis by Iorio, Raffaele, Damato, Valentina, Alboini, Paolo Emilio, Evoli, Amelia

“…Myasthenia gravis is an autoimmune disorder of the neuromuscular junction caused by circulating antibodies specif ic for the post-synaptic acetylcholine…”
Get full text

Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients by Iorio, Raffaele, Damato, Valentina, Evoli, Amelia, Gessi, Marco, Gaudino, Simona, Di Lazzaro, Vincenzo, Spagni, Gregorio, Sluijs, Jacqueline A, Hol, Elly M

“…ObjectiveTo report the clinical and immunological characteristics of 22 new patients with glial fibrillar acidic protein (GFAP) autoantibodies.MethodsFrom…”
Get full text

Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts by Guptill, Jeffrey T., Sanders, Donald B., Evoli, Amelia

“…Introduction: Myasthenia gravis (MG) patients with autoantibodies to muscle‐specific tyrosine kinase (MuSK) represent a distinct subset of those with this…”
Get full text

Randomized Trial of Thymectomy in Myasthenia Gravis by Wolfe, Gil I, Kaminski, Henry J, Aban, Inmaculada B, Minisman, Greg, Kuo, Hui-Chien, Marx, Alexander, Ströbel, Philipp, Mazia, Claudio, Oger, Joel, Cea, J. Gabriel, Heckmann, Jeannine M, Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O, Beydoun, Said R, Chalk, Colin H, Barboi, Alexandru C, Amato, Anthony A, Shaibani, Aziz I, Katirji, Bashar, Lecky, Bryan R.F, Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Márcia, Pulley, Michael T, Rivner, Michael H, Kostera-Pruszczyk, Anna, Pascuzzi, Robert M, Jackson, Carlayne E, Garcia Ramos, Guillermo S, Verschuuren, Jan J.G.M, Massey, Janice M, Kissel, John T, Werneck, Lineu C, Benatar, Michael, Barohn, Richard J, Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Odenkirchen, Joanne, Sonett, Joshua R, Jaretzki, Alfred, Newsom-Davis, John, Cutter, Gary R

“…In patients with nonthymomatous myasthenia gravis, thymectomy plus prednisone was associated with better clinical outcomes than prednisone alone. Patients…”
Get full text

Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? by Monte, Gabriele, Spagni, Gregorio, Damato, Valentina, Iorio, Raffaele, Marino, Mariapaola, Evoli, Amelia

“…Background Anti-acetylcholine receptor antibodies (AChR Abs) are detected in 85% of myasthenia gravis (MG) patients, at higher rates in patients with…”
Get full text

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis by Howard, James F, Bril, Vera, Burns, Ted M, Mantegazza, Renato, Bilinska, Malgorzata, Szczudlik, Andrzej, Beydoun, Said, Garrido, Francisco Javier Rodriguez De Rivera, Piehl, Fredrik, Rottoli, Mariarosa, Van Damme, Philip, Vu, Tuan, Evoli, Amelia, Freimer, Miriam, Mozaffar, Tahseen, Ward, E Sally, Dreier, Torsten, Ulrichts, Peter, Verschueren, Katrien, Guglietta, Antonio, de Haard, Hans, Leupin, Nicolas, Verschuuren, Jan J.G.M

“…OBJECTIVETo investigate safety and explore efficacy of efgartigimod (ARGX-113), an anti-neonatal Fc receptor immunoglobulin G1 Fc fragment, in patients with…”
Get full text

Disease specific enrichment of circulating let-7 family microRNA in MuSK + myasthenia gravis by Punga, Tanel, Bartoccioni, Emanuela, Lewandowska, Marta, Damato, Valentina, Evoli, Amelia, Punga, Anna Rostedt

“…Abstract Myasthenia gravis (MG) patients with antibodies against the muscle specific tyrosine kinase (MuSK +) have predominantly involvement of cranio-bulbar…”
Get full text

In sickness and in health: when myasthenia gravis is a conjugal matter by Alboini, Paolo Emilio, Spagni, Gregorio, Evoli, Amelia

“…Objective Genes and environment contribute to the multifactorial etiology of autoimmune diseases. Familial clusters of autoimmune diseases are often observed…”
Get full text

Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis by Marino, Mariapaola, Basile, Umberto, Spagni, Gregorio, Napodano, Cecilia, Iorio, Raffaele, Gulli, Francesca, Todi, Laura, Provenzano, Carlo, Bartoccioni, Emanuela, Evoli, Amelia

“…The use of rituximab (RTX), an anti-CD20 monoclonal antibody (Ab), in refractory myasthenia gravis (MG) is associated with a better response in patients with…”
Get full text

Editorial: News and Views in the Management of Myasthenia Gravis by Evoli, Amelia, Gilhus, Nils Erik, Guptill, Jeffrey

Get full text

Benefit and danger from immunotherapy in myasthenia gravis by Rodolico, Carmelo, Nicocia, Giulia, Damato, Valentina, Antonini, Giovanni, Liguori, Rocco, Evoli, Amelia

“…In the last years, significant advances have improved the knowledge of myasthenia gravis (MG) immunopathogenesis and have enabled to realize new molecules with…”
Get full text

Minimal manifestation status and prednisone withdrawal in the MGTX trial by Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.

“…OBJECTIVETo examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients…”
Get full text

Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis by Marino, Mariapaola, Scuderi, Flavia, Samengo, Daniela, Saltelli, Giorgia, Maiuri, Maria Teresa, Shen, Chengyong, Mei, Lin, Sabatelli, Mario, Pani, Giovambattista, Antonini, Giovanni, Evoli, Amelia, Bartoccioni, Emanuela

“…Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while…”
Get full text

Thirty-Five–Year Follow-Up Analysis of Clinical and Pathologic Outcomes of Thymoma Surgery by Margaritora, Stefano, MD, Cesario, Alfredo, MD, Cusumano, Giacomo, MD, Meacci, Elisa, MD, D'Angelillo, Rolando, MD, Bonassi, Stefano, Carnassale, Giulia, MD, Porziella, Venanzio, MD, Tessitore, Adele, MD, Vita, Maria Letizia, MD, Lauriola, Libero, MD, Evoli, Amelia, Granone, Pierluigi, MD

“…Background The impact of myasthenia gravis on patients with thymoma is still controversial when perioperative and long-term outcomes are analyzed. With the…”
Get full text

Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients by Bartoccioni, Emanuela, Provenzano, Carlo, Gulli, Francesca, Alboini, Paolo Emilio, Pocino, Krizia, Napodano, Cecilia, Marino, Mariapaola, Basile, Umberto, Evoli, Amelia

“…Background. Serological levels of free immunoglobulin light chains (FLCs), produced in excess of heavy chains during synthesis of immunoglobulins by plasma…”
Get full text

Management challenges in muscle-specific tyrosine kinase myasthenia gravis by Evoli, Amelia, Alboini, Paolo E., Bisonni, Ana, Mastrorosa, Alessia, Bartocccioni, Emanuela

“…Myasthenia gravis with antibodies to muscle‐specific tyrosine kinase (MuSK‐MG) is generally considered a severe disease because of the associated weakness…”
Get full text